Qinghai Spring Medicinal Resources Technology Co., Ltd.
600381.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CN¥270 | CN¥214 | CN¥160 | CN¥128 |
| % Growth | 26.4% | 33.5% | 25.4% | – |
| Cost of Goods Sold | CN¥197 | CN¥85 | CN¥86 | CN¥103 |
| Gross Profit | CN¥74 | CN¥129 | CN¥74 | CN¥25 |
| % Margin | 27.2% | 60.4% | 46.1% | 19.7% |
| R&D Expenses | CN¥15 | CN¥12 | CN¥11 | CN¥10 |
| G&A Expenses | CN¥17 | CN¥21 | CN¥14 | CN¥12 |
| SG&A Expenses | CN¥144 | CN¥192 | CN¥137 | CN¥68 |
| Sales & Mktg Exp. | CN¥127 | CN¥171 | CN¥123 | CN¥56 |
| Other Operating Expenses | CN¥109 | CN¥187 | CN¥53 | CN¥49 |
| Operating Expenses | CN¥269 | CN¥390 | CN¥202 | CN¥126 |
| Operating Income | -CN¥195 | -CN¥259 | -CN¥296 | -CN¥204 |
| % Margin | -72.1% | -121.1% | -184.5% | -159.7% |
| Other Income/Exp. Net | -CN¥6 | -CN¥1 | CN¥0 | CN¥0 |
| Pre-Tax Income | -CN¥201 | -CN¥260 | -CN¥295 | -CN¥252 |
| Tax Expense | -CN¥4 | CN¥6 | -CN¥8 | -CN¥4 |
| Net Income | -CN¥199 | -CN¥268 | -CN¥288 | -CN¥249 |
| % Margin | -73.5% | -125.2% | -179.5% | -194.6% |
| EPS | -0.34 | -0.46 | -0.49 | -0.42 |
| % Growth | 26.1% | 6.1% | -16.7% | – |
| EPS Diluted | -0.34 | -0.46 | -0.49 | -0.42 |
| Weighted Avg Shares Out | 585 | 582 | 587 | 587 |
| Weighted Avg Shares Out Dil | 585 | 582 | 587 | 587 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥1 | CN¥1 | CN¥0 | CN¥1 |
| Interest Expense | CN¥1 | CN¥1 | CN¥0 | CN¥0 |
| Depreciation & Amortization | CN¥30 | CN¥28 | CN¥41 | CN¥43 |
| EBITDA | -CN¥171 | -CN¥232 | -CN¥167 | -CN¥179 |
| % Margin | -63.2% | -108.4% | -104.3% | -140% |